N
ext-gen sequencing pioneer Illumina says it may soon usher in the era of the $100 genome — which could, in theory, make consumer genomics orders of magnitude more accessible.
CEO Francis deSouza on Monday unveiled a new machine, called the NovaSeq, at this year’s J.P. Morgan Healthcare Conference in San Francisco. He said the machine’s scanning speed has increased to a pace that could unravel the DNA of an entire human genome in an hour.
Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
Genome sequencing in broiler genetic
I call B.S. They just lost the lawsuit against Oxford Nanopore and now they’re trying to dangle the possibility that they can compete with nanopore’s cost. I really doubt they can with the current technology they’re using.
I’m sorry, but no-one from Illumina has said soon. The NovaSeq will one day be capable of $100 genome, but at the moment, the library prep alone costs $150, and then sequencing comes on top. Best price from NovaSeq is $1000 per genome. It will take years before we hit $100.
See http://www.opiniomics.org/hiseq-move-over-here-comes-nova-a-first-look-at-illumina-novaseq/ for more technical detail